Metabasis buys Cengent's PTP-1B metabolic program

MBRX acquired a protein tyrosine phosphatase 1B ( PTP-1B) program for metabolic diseases from note holders of Cengent (San Diego, Calif.). The program includes several lead compounds and compound libr...